Results 21 to 30 of about 3,214 (184)

Glycerophosphodiester Phosphodiesterase Identified as Non-Reliable Serological Marker for Borrelia miyamotoi Disease [PDF]

open access: yesMicroorganisms, 2020
The relapsing fever group Borrelia miyamotoi is an emerging tick-borne pathogen. Diagnosis of infection is currently mainly based on serological methods detecting antibodies against B. miyamotoi glycerophosphodiester phosphodiesterase (GlpQ).
Michael Reiter   +9 more
doaj   +2 more sources

Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient. [PDF]

open access: yesOpen Forum Infect Dis, 2022
Abstract Borrelia miyamotoi is an underdiagnosed cause of tick-borne illness in endemic regions and, in rare cases, causes neurological disease in immunocompetent patients. Here, we present a case of serologically confirmed Borrelia miyamotoi meningoencephalitis in an otherwise healthy patient who rapidly improved following initiation of
Gandhi S   +7 more
europepmc   +3 more sources

Borrelia miyamotoi Infections in Small Mammals, California, USA [PDF]

open access: yesEmerging Infectious Diseases, 2018
Surveillance to investigate the wildlife–vector transmission cycle of the human pathogen Borrelia miyamotoi in California, USA, revealed infections in dusky-footed woodrats, brush mice, and California mice.
Daniel J. Salkeld   +4 more
doaj   +3 more sources

Characterization of a Borrelia miyamotoi membrane antigen (BmaA) for serodiagnosis of Borrelia miyamotoi disease. [PDF]

open access: yesTicks Tick Borne Dis, 2020
Borrelia miyamotoi is a tick-borne pathogen that causes Borrelia miyamotoi disease (BMD), an emerging infectious disease of increasing public health significance. B. miyamotoi is transmitted by the same tick vector (Ixodes spp.) as B. burgdorferi sensu lato (s.l.), the causative agent of Lyme disease, therefore laboratory assays to differentiate BMD ...
Harris EK   +6 more
europepmc   +3 more sources

Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi. [PDF]

open access: yesMicrobiol Spectr, 2022
Hoornstra D   +11 more
europepmc   +2 more sources

Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors. [PDF]

open access: yesPLoS One, 2020
The western blacklegged tick, Ixodes pacificus, an important vector in the western United States of two zoonotic spirochetes: Borrelia burgdorferi (also called Borreliella burgdorferi), causing Lyme disease, and Borrelia miyamotoi, causing a relapsing fever-type illness. Human cases of Lyme disease are well-documented in California, with increased risk
Brummitt SI   +11 more
europepmc   +7 more sources

Molecular detection and identification of relapsing fever Borrelia in ticks and wild small mammals in China

open access: yesEmerging Microbes and Infections, 2022
We identified relapsing fever (RF) Borrelia in 1.45% (145/10426) of the ticks and 1.40% (40/2850) of the wild mammals in a field investigation in China.
Xiao-Ai Zhang   +12 more
doaj   +1 more source

Etymologia: Borrelia miyamotoi [PDF]

open access: yesEmerging Infectious Diseases, 2014
doaj   +2 more sources

Borrelia miyamotoi Disease Rash. [PDF]

open access: yesIntern Med, 2018
Hayashi T, Miura Y, Kawabata H.
europepmc   +3 more sources

Eco-epidemiology of Borrelia miyamotoi and Lyme borreliosis spirochetes in a popular hunting and recreational forest area in Hungary [PDF]

open access: yes, 2015
BACKGROUND: Borrelia miyamotoi, the newly discovered human pathogenic relapsing fever spirochete, and Borrelia burgdorferi sensu lato are maintained in natural rodent populations. The aim of this study was to investigate the natural cycle of B. miyamotoi
Coipan, Elena Claudia   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy